S&P Futures
6,012.00 +5.50 (+0.09%) Dow Futures
44,861.00 +35.00 (+0.08%) Nasdaq Futures
20,898.00 +17.75 (+0.09%) Russell 2000 Futures
2,444.60 -6.40 (-0.26%) Crude Oil
69.55 +0.61 (+0.88%) Gold
2,630.70 +12.20 (+0.47%)
Peijia Medical Limited (9996.HK)
| Previous Close | 3.740 |
| Open | 3.740 |
| Bid | 3.640 x N/A |
| Ask | 3.700 x N/A |
| Day's Range | 3.700 - 3.800 |
| 52 Week Range | 2.160 - 8.340 |
| Volume | |
| Avg. Volume | 1,271,212 |
| Market Cap | 2.507B |
| Beta (5Y Monthly) | 0.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.400 |
| Earnings Date | Aug 23, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.50 |
Simply Wall St.Discovering Opportunities Abu Dhabi Ship Building PJSC Among 3 Promising Penny Stocks
Global markets have recently experienced significant movements, with U.S. stocks rallying to record highs following a "red sweep" in the elections, indicating investor optimism about potential economic growth and tax reforms. Amidst these developments, investors are increasingly looking beyond traditional large-cap stocks to explore opportunities in smaller companies, often referred to as penny stocks. Although the term "penny stock" may seem outdated, it still captures the essence of...
PR NewswireAchieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical
Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its wholly-owned subsidiary, Achieva Medical Limited ("Achieva Medical"), entered into an exclusive distribution agreement with Jiangsu NowYon Medical Limited ("NowYon Medical"). The agreement marks a significant milestone in the expansion of Peijia Medical's Neurointerventional Business in the Greater China region.
